Go to deals
Healthcare

Intergrin has raised financing provided by Kartesia

Intergrin has obtained a unitranche loan of approximately US$59 million to refinance existing debt and to further support the growth of different healthcare and well-being initiatives.

Intergrin is a Dutch healthcare provider that operates clinics focused on specialized mental healthcare through its two brands, Het Rughuis and PHI. The company is headquartered in Geleen and currently has twelve treatment locations across the south of the country. Het Rughuis provides psychosomatic treatments to individuals with spine-related pain disorders through a combination of expert cognitive behavioral therapy, lifestyle-as-a-medicine therapy, vitality and physical therapy. PHI offers specialized psychosomatic mental healthcare to those suffering from anxiety, depression, somatoform disorder and serious unexplained physical complaints. Intergrin has unrivalled high success rates and delivers sustainable results, thereby significantly improving the quality of life of patients while also lowering the medical costs to society.

The loan was provided by Kartesia, a pan-European, independent and privately owned specialist provider of financing solutions, focused on offering customized resources across the capital structure to leading mid-market companies from a wide range of industries, with the view to accelerate their pace of growth.

Oaklins’ debt advisory team in the Netherlands advised Intergrin in this transaction and assisted in establishing a financing package aligned with the current business profile and future growth ambitions. This transaction emphasizes Oaklins’ strong track record in the healthcare clinics sector, which previously included deals such as Tandarts Today, Curious Kids and Dutch Dental Group.

“We are very pleased with our partnership with Kartesia. It enables us to pursue our ambitious goals, within the Netherlands and in international markets. We will refine our treatment methodology even further and we will invest in HealthTech applications. With these funds we will be able to help many patients who suffer from severe health disorders.”

Ron Joosten and Marc Kuijpers

Founders, Intergrin

Talk to the deal team

Bas Stoetzer

Partner
Amsterdam, Netherlands
Oaklins Netherlands

Robert Boersma

Partner
Amsterdam, Netherlands
Oaklins Netherlands

Casper Oude Essink

Director
Amsterdam, Netherlands
Oaklins Netherlands

Niels Vermuë

Associate Director
Amsterdam, Netherlands
Oaklins Netherlands

Related deals

Rare Patient Voice has been acquired by Konovo
Healthcare | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Learn more
GSP Group has secured an upsized growth refinancing package from HSBC
Business Support Services | Construction & Engineering Services

GSP Group has secured an upsized growth refinancing package from HSBC

The GSP Group has refinanced its growth facilities through an upsized financing package provided by HSBC.

Learn more
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more